Updated on Jun 30, 2022 | Health Navigator
The Los Angeles Times reported: “Use of unapproved Ebola drug ZMapp could lead to unintended, negative consequences, experts say. Distribute an experimental Ebola drug to West African patients? Not so fast, medical experts and ethicists say. Is an experimental Ebola drug helping Kent Brantly and Nancy Writebol? There’s probably no way to know.”
“Patient advocates who believe the drug is helpful are asking when it can be made available to the hundreds of West Africans who are ill.”
(more…)
Updated on Jun 30, 2022 | Health Navigator
An Inside Edition article so quoted Dr. Dalilah Restrepo, an infectious disease specialist at Mount Sinai Roosevelt Hospital.
Dr. Restrepo explained, “First, you wear a yellow gown. We would use a mask with a face shield because you want the extra protection in the eye area.”
(more…)
Updated on Jun 30, 2022 | Health Navigator
A recent Time article noted: “…National Institutes of Health immunologist Dr. Anthony Fauci told CBS This Morning that his research team is working on a vaccine to prevent Ebola, which is completely effective in monkeys, and will be tested in humans in September. And he’s not the only one developing a treatment for the deadly disease. The question is: Should experimental treatments be rushed into practice, given the breadth of this outbreak?”
(more…)
Updated on Jun 30, 2022 | Health Navigator
A New York Daily News article noted: “In the age of modern medicine, scientists are feverishly working to find a cure for the deadly Ebola virus, which can kill up to 90% of those it infects. But the disease is a tricky one, able to outsmart its host and entrench itself quickly.”
“When you’re infected with a virus, your cells sense the presence of an infection and respond by making a variety of proteins designed to stop the virus from replicating,” said Dr. Christopher Basler, a microbiology professor at Icahn School of Medicine at Mount Sinai. “Ebola has mechanisms that disable these innate immune responses.”
(more…)
Updated on Jun 30, 2022 | Health Navigator
A CBS News story noted: “A manual published in 2007 by the CDC, “Guidelines for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings,” outlines protocols that should be adhered when caring for patients with Ebola.”
“The report recommends health care workers wear single gloves for routine care and double gloves during surgery and other invasive procedures that could potentially pose risk for blood exposure. It’s also highly recommended that anyone in contact with an Ebola patient wears eye protection, such as goggles or a face shield, since the disease is easily contracted with fluid contact to the mucous membrane such as the tissue of the eyes. Additionally, health care workers should wear fluid-resistant gowns.”
(more…)
Updated on Jun 30, 2022 | Health Navigator
An article in The Hill noted: ”Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention (CDC), expressed confidence Sunday that health officials could stop a deadly outbreak of the Ebola virus in Africa.”
“’Ebola’s scary and it’s understandable that with a deadly disease, people are concerned. But the plain truth is that we can stop Ebola. We know how to control it,’ said Frieden on ABC’s “This Week.”” “Hospital infection control, and stopping it at the source in Africa.”
“…Frieden said that it was impossible to “hermetically seal the borders of the U.S. ‘We’re reliant and interdependent with the world for travel, for trade, for economy, for our families and communities,’ he added.”
(more…)
The Los Angeles Times reported: “Use of unapproved Ebola drug ZMapp could lead to unintended, negative consequences, experts say. Distribute an experimental Ebola drug to West African patients? Not so fast, medical experts and ethicists say. Is an experimental Ebola drug helping Kent Brantly and Nancy Writebol? There’s probably no way to know.”
